![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 33, 29973-29982, August 16, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Previous studies have demonstrated that AKT1 and
AKT3 are activated by heat shock and oxidative stress via both
phosphatidylinositol 3-kinase-dependent and -independent
pathways. However, the activation and role of AKT2 in the stress
response have not been fully elucidated. In this study, we show that
AKT2 in epithelial cells is activated by UV-C irradiation, heat shock,
and hyperosmolarity as well as by tumor necrosis factor
Inhibition of JNK by Cellular Stress- and Tumor Necrosis
Factor
-induced AKT2 through Activation of the NF
B Pathway in
Human Epithelial Cells*
§¶,
,
,
§,
,
,
, and
§**
Department of Pathology and
§ Molecular Oncology and Drug Discovery Program, University
of South Florida College of Medicine and H. Lee Moffitt Cancer Center
and Research Institute, Tampa, Florida 33612 and
Cancer
Research Department, Berlex Biosciences,
Richmond, California 94804
(TNF
)
through a phosphatidylinositol 3-kinase-dependent pathway.
The activation of AKT2 inhibits UV- and TNF
-induced c-Jun N-terminal
kinase (JNK) and p38 activities that have been shown to be required for
stress- and TNF
-induced programmed cell death. Moreover, AKT2
interacts with and phosphorylates I
B kinase
. The phosphorylation
of I
B kinase
and activation of NF
B mediates AKT2 inhibition
of JNK but not p38. Furthermore, phosphatidylinositol 3-kinase
inhibitor or dominant negative AKT2 significantly enhances UV- and
TNF
-induced apoptosis, whereas expression of constitutively active
AKT2 inhibits programmed cell death in response to UV and TNF
stimulation with an accompanying decreased JNK and p38 activity. These
results indicate that activated AKT2 protects epithelial cells from
stress- and TNF
-induced apoptosis by inhibition of stress kinases
and provide the first evidence that AKT inhibits stress kinase JNK
through activation of the NF
B pathway.
*
This work was supported by NCI, National Institutes of
Health Grants CA77935 and CA89242 and Department of Defense Grants DAMD17-00-0559 and DAMD 17-01-1-0394.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
H. J. Ting, J. P. Stice, U. Y. Schaff, D. Y. Hui, J. C. Rutledge, A. A. Knowlton, A. G. Passerini, and S. I. Simon Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-{alpha} Circ. Res., February 16, 2007; 100(3): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horiguchi, S. Arai, T. Nishihara, and J.-i. Nishikawa AIB1 Promotes DNA Replication by JNK Repression and AKT Activation during Cellular Stress J. Biochem., September 1, 2006; 140(3): 409 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Liu, S. Kaneko, L. Yang, R. I. Feldman, S. V. Nicosia, J. Chen, and J. Q. Cheng Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215 J. Biol. Chem., December 10, 2004; 279(50): 52175 - 52182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mabuchi, M. Ohmichi, Y. Nishio, T. Hayasaka, A. Kimura, T. Ohta, J. Kawagoe, K. Takahashi, N. Yada-Hashimoto, H. Seino-Noda, et al. Inhibition of Inhibitor of Nuclear Factor-{kappa}B Phosphorylation Increases the Efficacy of Paclitaxel in in Vitro and in Vivo Ovarian Cancer Models Clin. Cancer Res., November 15, 2004; 10(22): 7645 - 7654. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dufour, M.-J. Demers, D. Gagne, A. B. Dydensborg, I. C. Teller, V. Bouchard, I. Degongre, J.-F. Beaulieu, J. Q. Cheng, N. Fujita, et al. Human Intestinal Epithelial Cell Survival and Anoikis: DIFFERENTIATION STATE-DISTINCT REGULATION AND ROLES OF PROTEIN KINASE B/Akt ISOFORMS J. Biol. Chem., October 15, 2004; 279(42): 44113 - 44122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mabuchi, M. Ohmichi, Y. Nishio, T. Hayasaka, A. Kimura, T. Ohta, M. Saito, J. Kawagoe, K. Takahashi, N. Yada-Hashimoto, et al. Inhibition of NF{kappa}B Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models J. Biol. Chem., May 28, 2004; 279(22): 23477 - 23485. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Dan, M. Sun, S. Kaneko, R. I. Feldman, S. V. Nicosia, H.-G. Wang, B. K. Tsang, and J. Q. Cheng Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP) J. Biol. Chem., February 13, 2004; 279(7): 5405 - 5412. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Q. Wang, T. Quan, T. He, T. F. Franke, J. J. Voorhees, and G. J. Fisher Epidermal Growth Factor Receptor-dependent, NF-{kappa}B-independent Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Inhibits Ultraviolet Irradiation-induced Caspases-3, -8, and -9 in Human Keratinocytes J. Biol. Chem., November 14, 2003; 278(46): 45737 - 45745. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-q. Yuan, R. I. Feldman, G. E. Sussman, D. Coppola, S. V. Nicosia, and J. Q. Cheng AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1: IMPLICATION OF AKT2 IN CHEMORESISTANCE J. Biol. Chem., June 20, 2003; 278(26): 23432 - 23440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. L. Leong, A. C. Maiyar, B. Kim, B. A. O'Keeffe, and G. L. Firestone Expression of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, Is a Cell Survival Response to Multiple Types of Environmental Stress Stimuli in Mammary Epithelial Cells J. Biol. Chem., February 14, 2003; 278(8): 5871 - 5882. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |